Lupin, Natco receives USFDA nod for Imatinib Mesylate tablets Farhat Nasim6 March 2019 9:30 AM ISTImatinib Mesylate is a generic version of Novartis Pharmaceuticals Corporation's Gleevec tablets in the same strengths, Lupin said in a filing to BSE....
Novartis and The Max Foundation transform pioneering cancer access program for people in lower-income countries Ruby Khatun Khatun25 Sept 2017 9:21 AM ISTBasel: Novartis announced a new collaboration with The Max Foundation to support continued access to treatment at no cost for nearly 34,000 current...